DNA Synthesizer Market Size To Reach $664.2 Million By 2030

DNA Synthesizer Market Growth & Trends

The global DNA synthesizer market size is expected to reach USD 664.2 million by 2030, expanding at 14.42% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The increasing interest for synthetic DNA in a wide range of applications including drug discovery and development, gene therapy, and genetic research is the key factor driving the demand for synthesizers. In addition, advancements in synthesis technology and automation are anticipated to further fuel the growth of the market. Moreover, various organic and inorganic developments done by market players in terms of development of efficient synthesizers is another factor supporting industry expansion. For instance, K&A Labs GmbH developed H series DNA synthesizers capable of giving maximum yield.

The evolving demand of synthetic nucleic acid across industries is pushing market players to invest in synthesizers. For instance, in April 2022 Ansa Biotechnologies raised USD 68 million to launch a customizable DNA synthesis service. Moreover, these funding has helped the company to strengthen its gene synthesis capabilities. Similarly, in June 2022 DNA Script raised USD 88.32 million to bring rapid synthesis platform to the lab. This funding supported the commercial launch of the company’s benchtop DNA synthesizers.

The industry is highly competitive, with market players emphasizing on developing new and innovative synthesizers that can give faster and more efficient nucleic acid synthesis capabilities. For instance, in September 2022, Codex DNA, Inc. announced the commercial release and first shipment of BioXp 9600 system, a new high throughput platform developed to revolutionize synthetic biology workflows. In addition, collaborations and partnerships between companies are becoming increasingly common, as companies seek to leverage each other's capabilities and strengths to foster growth and innovation in the market.

Furthermore, exponential rise in demand for DNA synthesizers and other synthesis platforms in pharmaceutical and biotechnological companies have driven the market to a significant extent. Also, rising R&D activities, supportive government legislation, and an increase in the demand for novel therapeutic regimens for rare diseases are supporting industry’s growth.

 Request a free sample copy or view report summary: DNA Synthesizer Market Report

DNA Synthesizer Market Report Highlights

• By type, the benchtop DNA synthesizers segment dominated in 2022 with a share of 72.72%, due to increasing investment in R&D, growing demand for custom synthesis capabilities, and robust demand from large range of end users

• By application, the drug discovery and development segment dominated the industry in 2022 with a share of 48.11%, due to Wide application of DNA synthesizers in drug discovery, technology advancements, rising adoption of high-throughput technology, and presence of large number of players

• By end-use, the pharmaceutical and biotechnology companies segment dominated the market in 2022 with a share of 52.37%. The high growth of the segment is attributed to the rising use of synthetic nucleic acid for developing novel genetic therapies. Whereas the academic and research institute segment is projected to grow at high rate

• North America dominated the market in 2022 with a share of 39.22% due to its highly developed healthcare infrastructure and favorable government policies

DNA synthesizer Market Segmentation

Grand View Research has segmented the global DNA synthesizer market on the basis of type, application, end-use, and region:

DNA synthesizer Type Scope Outlook (Revenue, USD Million, 2018 - 2030)

• Benchtop DNA Synthesizers

• Large-scale DNA Synthesizers

DNA synthesizer Application Scope Outlook (Revenue, USD Million, 2018 - 2030)

• Drug Discovery & Development

• Genetic Engineering

• Clinical Diagnostics

DNA synthesizer End-use Scope Outlook (Revenue, USD Million, 2018 - 2030)

• Academic & Research Institutes

• Pharmaceutical & Biotechnology Companies

• Clinical Laboratories

DNA synthesizer Regional Scope Outlook (Revenue, USD Million, 2018 - 2030)

• North America

• U.S.

• Canada

• Europe

• UK

• Germany

• France

• Italy

• Spain

• Denmark

• Sweden

• Norway

• Asia Pacific

• Japan

• China

• India

• Australia

• Thailand

• South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of DNA Synthesizer Market

• Danaher

• Twist Bioscience

• Kilobaser

• LGC Limited

• CSBio

• K&A Labs GmbH

• DNA Script

• OligoMaker ApS

• PolyGen GmbH

• Biolytic Lab Performance Inc.